IPCA Laboratories Ltd banner

IPCA Laboratories Ltd
NSE:IPCALAB

Watchlist Manager
IPCA Laboratories Ltd Logo
IPCA Laboratories Ltd
NSE:IPCALAB
Watchlist
Price: 1 521.3 INR -0.21% Market Closed
Market Cap: ₹386B

Balance Sheet

Balance Sheet Decomposition
IPCA Laboratories Ltd

Balance Sheet
IPCA Laboratories Ltd

Rotate your device to view
Balance Sheet
Currency: INR
Mar-2002 Mar-2003 Mar-2004 Mar-2005 Mar-2006 Mar-2007 Mar-2008 Mar-2009 Mar-2010 Mar-2011 Mar-2012 Mar-2013 Mar-2014 Mar-2015 Mar-2016 Mar-2017 Mar-2018 Mar-2019 Mar-2020 Mar-2021 Mar-2022 Mar-2023 Mar-2024 Mar-2025
Assets
Cash & Cash Equivalents
38
36
61
50
55
101
94
107
108
91
106
167
142
630
243
275
276
260
584
1 660
2 752
12 579
2 089
1 672
Cash
0
0
0
0
0
0
0
0
0
0
0
0
0
613
227
262
262
254
547
1 060
722
917
1 388
1 283
Cash Equivalents
38
36
61
50
55
101
94
107
108
91
106
167
142
17
16
13
14
6
37
600
2 030
11 662
701
388
Short-Term Investments
26
0
0
0
0
0
0
52
53
25
22
402
604
963
1 447
1 155
1 911
3 456
3 598
6 028
10 949
9 222
6 364
9 379
Total Receivables
1 449
1 423
1 611
1 764
1 651
2 193
3 318
3 993
4 607
4 181
3 720
4 509
5 021
8 029
5 862
6 736
8 160
8 902
10 783
10 325
11 547
11 962
19 271
21 927
Accounts Receivables
987
1 215
1 375
1 519
1 377
1 807
2 595
3 391
3 880
3 672
3 449
4 178
4 495
6 386
4 502
5 120
6 063
6 840
8 993
8 157
9 180
10 336
17 044
18 891
Other Receivables
462
208
236
245
274
386
723
602
727
509
271
331
526
1 643
1 360
1 616
2 097
2 062
1 790
2 168
2 367
1 626
2 227
3 036
Inventory
969
1 057
1 557
1 792
1 872
2 363
2 676
3 062
3 802
4 664
6 699
7 410
8 476
9 343
8 420
8 884
8 875
10 962
13 384
16 106
18 897
17 732
25 120
25 994
Other Current Assets
0
0
0
0
0
0
0
178
480
1 407
1 553
1 484
1 781
383
249
291
234
199
208
251
428
398
2 545
699
Total Current Assets
2 483
2 516
3 229
3 606
3 577
4 657
6 088
7 392
9 050
10 368
12 100
13 972
16 023
19 348
16 219
17 340
19 455
23 778
28 557
34 370
44 572
51 893
55 389
59 670
PP&E Net
1 434
1 681
2 132
3 178
3 702
4 299
5 407
5 887
6 761
7 842
10 046
11 790
14 466
19 532
20 355
19 755
18 954
17 826
19 933
21 465
25 026
26 946
46 632
46 853
PP&E Gross
1 434
1 681
2 132
3 178
3 702
4 299
5 407
5 887
0
7 842
10 046
11 790
14 466
19 532
20 355
19 755
18 954
17 826
19 933
21 465
25 026
26 946
46 632
46 853
Accumulated Depreciation
555
803
951
879
1 073
1 311
1 588
1 956
0
2 810
3 849
4 638
5 606
7 135
1 536
3 145
4 788
6 441
8 185
9 938
11 891
14 306
22 535
25 747
Intangible Assets
0
0
13
56
42
25
13
25
0
98
104
151
257
536
602
552
834
1 770
1 363
1 142
1 672
1 591
1 426
1 127
Goodwill
0
0
0
0
0
0
0
0
0
0
236
393
462
472
472
472
472
472
624
466
542
381
906
906
Note Receivable
0
0
0
0
0
0
0
0
0
376
376
479
713
954
816
1 114
1 160
1 269
1 307
1 887
1 731
1 530
1 210
2 235
Long-Term Investments
20
19
20
28
36
86
95
412
325
407
339
89
90
193
258
222
175
301
713
1 114
2 699
3 027
3 036
2 163
Other Long-Term Assets
1
2
1
1
0
19
17
31
35
28
72
96
92
213
195
140
123
93
101
240
148
897
2 413
4 651
Other Assets
0
0
0
0
0
0
0
0
0
0
236
393
462
472
472
472
472
472
624
466
542
381
906
906
Total Assets
3 938
N/A
4 217
+7%
5 396
+28%
6 868
+27%
7 358
+7%
9 086
+23%
11 619
+28%
13 746
+18%
16 172
+18%
19 118
+18%
23 273
+22%
26 970
+16%
32 103
+19%
41 248
+28%
38 917
-6%
39 595
+2%
41 173
+4%
45 507
+11%
52 598
+16%
60 684
+15%
76 389
+26%
86 264
+13%
111 013
+29%
117 606
+6%
Liabilities
Accounts Payable
316
275
426
517
542
670
680
668
698
1 786
2 345
2 684
3 413
3 060
4 211
4 577
4 235
5 243
6 099
6 649
5 577
5 251
7 761
8 462
Accrued Liabilities
1
2
4
19
24
22
39
49
122
131
248
300
394
429
253
244
199
176
285
300
527
379
949
658
Short-Term Debt
103
99
167
74
219
232
262
274
498
2 634
2 014
1 571
1 439
6 433
1 849
1 773
2 390
2 097
3 110
1 766
3 678
6 618
5 592
4 953
Current Portion of Long-Term Debt
0
0
0
0
0
0
0
0
0
722
695
937
1 646
1 059
1 981
1 867
1 545
1 144
738
714
327
1 506
2 588
2 734
Other Current Liabilities
274
307
435
361
420
505
626
1 171
836
513
1 100
844
1 041
1 536
1 406
1 098
1 707
2 315
3 033
2 177
4 550
4 305
6 666
7 057
Total Current Liabilities
694
682
1 033
971
1 205
1 428
1 607
2 162
2 155
5 785
6 402
6 337
7 933
12 517
9 700
9 559
10 076
10 975
13 264
11 605
14 659
18 058
23 556
23 862
Long-Term Debt
1 446
1 304
1 549
2 207
1 969
2 389
3 530
4 594
4 545
1 946
3 302
3 662
2 940
4 987
4 843
3 517
2 340
1 409
1 160
174
4 067
6 689
6 203
5 941
Deferred Income Tax
237
249
290
429
479
531
590
682
829
807
932
1 304
1 471
1 584
1 565
1 705
1 597
1 476
1 418
1 336
1 526
1 892
3 105
2 950
Minority Interest
0
1
1
0
0
0
0
4
6
7
0
0
0
0
0
0
0
155
136
145
769
733
13 948
14 398
Other Liabilities
0
0
0
0
0
0
0
0
0
70
98
129
162
194
218
261
274
268
345
407
448
473
878
970
Total Liabilities
2 377
N/A
2 235
-6%
2 872
+29%
3 608
+26%
3 653
+1%
4 348
+19%
5 727
+32%
7 433
+30%
7 523
+1%
8 602
+14%
10 733
+25%
11 432
+7%
12 506
+9%
19 282
+54%
16 325
-15%
15 043
-8%
14 287
-5%
14 283
0%
16 324
+14%
13 667
-16%
21 469
+57%
27 844
+30%
47 691
+71%
48 121
+1%
Equity
Common Stock
125
125
125
250
250
250
251
250
250
251
252
252
252
252
252
252
252
253
253
254
254
254
254
254
Retained Earnings
1 044
1 465
2 007
2 743
3 195
4 231
5 363
6 031
7 653
9 798
12 145
14 792
18 839
21 137
21 936
23 859
26 119
30 431
35 382
45 657
53 540
57 219
62 189
68 519
Additional Paid In Capital
392
392
392
267
267
267
299
341
385
424
436
440
440
440
440
440
440
489
489
965
965
965
965
965
Unrealized Security Profit/Loss
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
65
60
Other Equity
0
0
0
0
7
10
20
309
361
43
294
54
65
136
37
1
75
51
151
141
161
18
21
194
Total Equity
1 561
N/A
1 982
+27%
2 524
+27%
3 260
+29%
3 705
+14%
4 738
+28%
5 892
+24%
6 313
+7%
8 649
+37%
10 516
+22%
12 540
+19%
15 538
+24%
19 597
+26%
21 965
+12%
22 592
+3%
24 553
+9%
26 886
+10%
31 224
+16%
36 275
+16%
47 017
+30%
54 920
+17%
58 420
+6%
63 322
+8%
69 485
+10%
Total Liabilities & Equity
3 938
N/A
4 217
+7%
5 396
+28%
6 868
+27%
7 358
+7%
9 086
+23%
11 619
+28%
13 746
+18%
16 172
+18%
19 118
+18%
23 273
+22%
26 970
+16%
32 103
+19%
41 248
+28%
38 917
-6%
39 595
+2%
41 173
+4%
45 507
+11%
52 598
+16%
60 684
+15%
76 389
+26%
86 264
+13%
111 013
+29%
117 606
+6%
Shares Outstanding
Common Shares Outstanding
250
250
250
250
250
250
251
250
250
251
252
252
252
252
252
252
252
253
253
254
254
254
254
254
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett